Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025

BUY
$258.78 - $328.31 $36,229 - $45,963
140 New
140 $36.5 Million
Q2 2021

May 19, 2025

SELL
$233.58 - $259.14 $281,230 - $312,004
-1,204 Closed
0 $0
Q1 2021

May 19, 2025

SELL
$221.91 - $258.6 $5,991 - $6,982
-27 Reduced 2.19%
1,204 $300 Million
Q4 2020

May 19, 2025

SELL
$216.38 - $257.67 $865 - $1,030
-4 Reduced 0.32%
1,231 $283 Million
Q3 2020

May 19, 2025

BUY
$234.65 - $260.95 $289,792 - $322,273
1,235 New
1,235 $314 Million
Q2 2020

May 19, 2025

BUY
$197.81 - $242.74 $52,815 - $64,811
267 Added 30.65%
1,138 $268 Million
Q1 2020

May 19, 2025

SELL
$182.24 - $241.7 $4,920 - $6,525
-27 Reduced 3.01%
871 $177 Million
Q4 2019

May 19, 2025

BUY
$189.21 - $243.2 $5,487 - $7,052
29 Added 3.34%
898 $216 Million
Q3 2019

May 19, 2025

BUY
$174.11 - $208.62 $5,745 - $6,884
33 Added 3.95%
869 $168 Million
Q2 2019

May 19, 2025

BUY
$166.7 - $195.41 $5,667 - $6,643
34 Added 4.24%
836 $154 Million
Q1 2019

May 19, 2025

BUY
$180.87 - $203.88 $145,057 - $163,511
802 New
802 $152 Million
Q4 2018

May 19, 2025

SELL
$178.4 - $208.25 $3,211 - $3,748
-18 Reduced 2.27%
774 $151 Million
Q3 2018

May 19, 2025

SELL
$185.29 - $208.89 $8,893 - $10,026
-48 Reduced 5.71%
792 $164 Million
Q2 2018

May 19, 2025

BUY
$166.05 - $186.51 $1,494 - $1,678
9 Added 1.08%
840 $155 Million
Q1 2018

May 19, 2025

SELL
$169.43 - $198.0 $169 - $198
-1 Reduced 0.12%
831 $142 Million
Q4 2017

May 19, 2025

BUY
$168.79 - $188.59 $506 - $565
3 Added 0.36%
832 $145 Million
Q3 2017

May 19, 2025

BUY
$167.29 - $191.0 $4,182 - $4,775
25 Added 3.11%
829 $155 Million
Q2 2017

May 19, 2025

SELL
N/A
-62 Reduced 7.16%
804 $138 Million
Q1 2017

May 19, 2025

BUY
N/A
866 New
866 $142 Million
Q4 2016

May 19, 2025

BUY
N/A
902
902 $132 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Heck Capital Advisors, LLC Portfolio

Follow Heck Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heck Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Heck Capital Advisors, LLC with notifications on news.